Clinical Trial Update: A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

A Phase 2b trial evaluating DU-176b for prevention of venous thromboembolism after total knee arthroplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Total Knee Arthroplasty
• Venous Thromboembolism

Drugs mentioned

• DU-176b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Venous Thromboembolism, Deep Vein Thrombosis | Phase 2 | Status: COMPLETED | Results posted: 2015-01-26